Page 151 - Oncology Coder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncology coder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncology Coder Today - Breaking & Trending Today

"Factors influencing the translation of shared cancer follow-up care in" by Tiffany Sandell and Heike Schütze

Background The increasing incidence of cancer, coupled with improved survivorship, has increased demand for cancer follow-up care and the need to find alternative models of care. Shared cancer follow-up care in general practice is a safe option in terms of quality of life and cancer recurrence; however, there are barriers to translating this into practice. This review aimed to identify factors that influence the translation of shared cancer follow-up care into clinical practice. Methods Systematic review. Seven electronic databases: MEDLINE, Science Citation Index, Academic Search Complete, CINAHL, APA Psychinfo, Health Source: Nursing/Academic Edition and Psychology and Behavioural Sciences Collection, were searched for published papers between January 1999 and December 2021. The narrative review included papers if they were available in full-text, English, peer-reviewed and focused on shared cancer follow-up care. Results Thirty-eight papers were included in the final review. Five ma ....

Health Source , Behavioural Sciences Collection , Science Citation Index , Academic Search Complete , Academic Edition , Rganisation Of Health Services , Public Health ,

Cellectis to Present Pre-Clinical Data on TALEN-edited Smart CAR T-cells Supporting Improved Solid Tumor Targeting at the Society for Immunotherapy of Cancers (SITC) 37th Annual Meeting

Back to all press releases New York, NY – October 5, 2022 - Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that pre-clinical data on TALEN®-edited smart CAR T-cel ....

New York , United States , Cellectis The Company Euronext Growth , Society For Immunotherapy Of Cancer , Senior Scientist Team Leader Immuno , Euronext Growth , Annual Meeting , Senior Scientist , Team Leader Immuno Oncology , Cancer Treatments , Industrial Goods Amp Services , Medical Specialties , Cancer Immunotherapy , Clinical Medicine , Tumor Antigen ,

Unlocking the potential of biosimilars for more sustainable care

Biosimilars, or alternatives to licensed biological therapies, can increase access to treatment and alleviate financial burdens on health care systems. ....

Optimising The Sustainability Of Health , Business And Competition , Drug And Device Safety , Generics And Biosimilars , Health Care , Patient Access , Society And Culture ,